Total Funding
33
Total FundingCorporate Round raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
150576
Rafael Pharmaceuticals is clinical-stage, metabolic oncology therapeutics company.
Sanjeev Luther: CEO
Robert Shorr: CEO
About the Company
Rafael Pharmaceuticals is a provider of metabolic oncology therapeutics intended to treat cancer patients. The company's metabolic oncology therapeutics applies unique bio-energetic processes specific to cancer and provide altered cancer metabolism directed therapies and novel, first-in-class drugs and drug delivery technologies, enabling
patients to get revolutionized cancer treatment.
